CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-26 | LIGAND PHARMACEUTICALS INC 10% owner | Sale | −94,488 | $8.11 | $766K | 5,819,383 |
| 2020-08-25 | LIGAND PHARMACEUTICALS INC 10% owner | Sale | −70,000 | $8.02 | $562K | 5,968,083 |
| 2020-06-30 | FOEHR MATTHEW W Director | Sale | −13,000 | $7.35 | $96K | 26,250 |
| 2020-03-31 | MORNEAU MICHAEL VP, Finance and Administration | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-01-19 | Lian Brian President & CEO | Shares withheld for taxes | −3,195 | $7.18 | $23K | 1,704,312 |
| 2020-01-19 | MORNEAU MICHAEL VP, Finance and Administration | Shares withheld for taxes | −2,044 | $7.18 | $15K | 92,840 |
| 2020-01-03 | MORNEAU MICHAEL VP, Finance and Administration | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-01-03 | Lian Brian President & CEO | Grant or award | +153,333 | 1,714,289 | ||
| 2020-01-03 | Lian Brian President & CEO | Shares withheld for taxes | −6,782 | $7.77 | $53K | 1,707,507 |
| 2020-01-03 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +345,000 | 345,000 | ||
| 2020-01-02 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2020-01-02 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2020-01-02 | FOEHR MATTHEW W Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2020-01-02 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2020-01-02 | Rowland Charles A Jr Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2020-01-02 | Rouan Sarah Kathryn Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2019-10-31 | MORNEAU MICHAEL VP, Finance and Administration | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2019-07-31 | MORNEAU MICHAEL VP, Finance and Administration | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-07-01 | Rouan Sarah Kathryn Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-01-19 | MORNEAU MICHAEL VP, Finance and Administration | Shares withheld for taxes | −2,044 | $8.78 | $18K | 91,991 |
Page 22 of 27 · 528 trades